Literature DB >> 6451220

Purification of the human complement control protein C3b inactivator.

L G Crossley, R R Porter.   

Abstract

An alternative method of isolation from human plasma is described for C3b inactivator, C3bINA, the proteinase that in conjunction with either beta 1H or C4b-binding protein will hydrolyse respectively C3b or C4b, the activation products of the third, C3 and fourth, C4, components of complement. The purification is by chromatography of plasma on columns of QAE-Sephadex, wheat-germ agglutinin-Sepharose, hydroxyapatite and Sephacryl S-200. The yield of C3bINA (6 mg from 500ml of plasma) is severalfold higher than in previously described methods. The sensitivity of the assay for C3bINA has been increased by including optimal amounts of beta 1H, and it was observed that beta 1H was essential for hydrolysis by C3bINA of C3b, whether the C3b was in solution or bound to a cell surface. Native C3 is not hydrolysed by C3bINA + beta 1H, but the haemolytically inactive form that appears on prolonged storage at 4 degrees C or on freezing and thawing is hydrolysed and gives fragments of the alpha-chain of 75000 and 43000 apparent mol.wt. As the alpha'-chain of C3b, which has lost an N-terminal peptide C3a, gives fragments of 67000 and 43000 apparent mol.wt. when incubated with C3bINA + beta 1H, this suggests that the larger fragment is N-terminal and the smaller one C-terminal. The pH optimum of C3bINA with soluble substrates is 6.0, but no clear classification of the type of proteinase to which this enzyme belongs has been obtained.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6451220      PMCID: PMC1162195          DOI: 10.1042/bj1910173

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

2.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

3.  Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding.

Authors:  Y Nagata; M M Burger
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

4.  Preparation of adsorbents for biospecific affinity chromatography. Attachment of group-containing ligands to insoluble polymers by means of bifuctional oxiranes.

Authors:  L Sundberg; J Porath
Journal:  J Chromatogr       Date:  1974-03-13

5.  Purification of wheat germ agglutinin by affinity chromatography.

Authors:  J H Shaper; R Barker; R L Hill
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

6.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

9.  Human anaphylatoxin (C3a) from the third component of complement. Primary structure.

Authors:  T E Hugli
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

10.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03
View more
  34 in total

1.  Characterization of three monoclonal antibodies against C3 with selective specificities.

Authors:  K Iida; K Mitomo; T Fujita; N Tamura
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

2.  Interactions between human complement components factor H, factor I and C3b.

Authors:  C J Soames; R B Sim
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.

Authors:  J M Yuan; L M Hsiung; J Gagnon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

4.  Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering.

Authors:  S J Perkins; K F Smith; R B Sim
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

Review 5.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Authors:  Linda Mark; David G Proctor; David J Blackbourn; Anna M Blom; O Brad Spiller
Journal:  Immunology       Date:  2007-08-30       Impact factor: 7.397

7.  Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.

Authors:  Lena Kask; Bruno O Villoutreix; Mårten Steen; Bala Ramesh; Björn Dahlbäck; Anna M Blom
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

8.  Non-enzymic activation of the covalent binding reaction of the complement protein C3.

Authors:  S K Law
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

9.  Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

Authors:  R D Campbell; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

10.  Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.

Authors:  E M Press; J Gagnon
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.